4 Site Addition

Attachment_A04_Site Addition

OMB# 0925•0753
Expiration Date 07/31/2021

Public reporting burden for this collection of information is estimated to average 10 minutes per
response, including the time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information. An agency
may not conduct or sponsor, and a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this
burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 208927974, ATTN: PRA (OMB#0925-0753). Do not return the completed form to this address.

Filling out PDF Forms
This PDF form contains “roll-over or double-click” help functionality.
This form allows you to enter data directly onto the screen. After completing the form, you
are able to print the document so that you can fax/mail the document.
To fill out a form:

1. Select the hand tool.
2. Position the pointer inside a field, and click to type text.
3. After entering text or selecting a check box, do one of the following:
- Press tab to accept the form field change and go to the next form field.
- Press Shift+Tab to accept the form field change and go to the previous form field.
- Press Enter (Windows) or Return (Mac OS) to accept the form field change and
deselect the current form field.

4. Once completed, print the form.

Attachment_A04_Site Addition

OMB# 0925-0753
Expiration Date: 07/31/2021

Cancer Trials Support Unit
Site Addition Form

(Utilized for the addition of a site to an existing IRB approval)

Submit to the CTSU Regulatory Office via the
Regulatory Submission Portal: www.ctsu.org.

This form can be utilized when an IRB has added an additional site to an existing IRB approval.
• This form can be submitted in lieu of an IRB approval letter if signed by an IRBsignatory.
• If not signed by an IRB signatory, an IRB approval letter must accompany this form.

•

If the approval applies to multiple protocols, attach a supplemental list of protocols to this form.

1) Protocol #:

2) Protocol Title: (Shortened version acceptable)

3a) Parent Institution Name (List the name of the parent
institution who has the current IRB approval):

3b) Parent Institution NCI Code (ALXXX):

4a) New Institution Name(s) (List the names of the new
institutions being added to the parent institution’s
approval)

4b ) New Institution NCI Code (ALXXX)

5) Principal Investigator:

6) NCI Investigator #:

This activity has been reviewed and approved by the IRB in accordance with the Common Rule and any other governing regulations
or subparts:
7) Approval Type:
8) Review Type:
Initial or Renewal ☐ Amendment ☐
Full Board ☐ Expedited ☐
9) Date of IRB or Designee Review in box 7:
mm

/

dd

/

10) OHRP IRB Registration Number:

yyyy

11) Comments:
The official signing below certifies that the information provided above is correct and that, as required, future reviews will be
performed & certification will be provided. Questions #1 through #17 must be completed for this form to be accepted.
Check here if this form is an IRB signatory as documented on the institutional assurance with OHRP ☐.
13) Name of approving IRB:
12) Name of IRB Signatory:
14) Title of IRB Signatory:

15) Phone

16) Signature:

17) Date:

Final_July_2018
_ by CTSU for local reproduction
Authorized

mm

(

)|
/

dd

/

|-|
yyyy

|